Tuesday, June 02, 2020 2:02:31 PM
REE;
Does anyone remember the Asset Sale milestone triggers? 18 months ago Medivir under Christine Lind shelved the remetinostat Phase III due to further discussions with the FDA over trial design. Did Medivir ever provide a further update, I don’t recall one. At the time I thought it was odd and a possible stalling tactic by Medivir to provide them more time to search for a licensing partner. Circling back to the Asset Sale, would a successful Phase 3 trigger a development payment and without a partner how would Medivir pay Tetralogic?
Either I missed something or Medivir has possible decided the best way to avoid paying Tetralogic is to find clever ways to slow down the development process. Input on this is very much appreciated. Thanks.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM